Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Mercer

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Molecular Genetics and Metabolism|June 1, 2013
Does early use of enzyme replacement therapy alter the natural history of mucopolysaccharidosis I? Experience in three siblingsSarah Laraway, Catherine Breen, Jean Mercer, et al.
International Journal of Pediatric Otorhinolaryngology|July 1, 2018
Transnasal adenoidectomy in mucopolysaccharidosisRebecca Harrison, Simone Schaefer, Laura Warner, et al.
The Journal of Pediatrics|October 30, 2016
Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type ISarah Laraway, Jean Mercer, Elisabeth Jameson, et al.
Plos One|September 19, 2018
Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapyAbhijit Ricky Pal, Jean Mercer, Simon A Jones, et al.
The Journal of Pediatrics|February 4, 2009
Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 patientsRobert F Wynn, Jean Mercer, Joanne Page, et al.
Journal of Inherited Metabolic Disease|March 19, 2011
The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome)Elke Miebach, Heather Church, Alan Cooper, et al.
Journal of Inherited Metabolic Disease|March 12, 2017
Long term survival and cardiopulmonary outcome in children with Hurler syndrome after haematopoietic stem cell transplantationSu Han Lum, Karolina M Stepien, Arunabha Ghosh, et al.
Human Genome Variation|October 22, 2016
Maternal mosaicism for <i>IDUA</i> deletion clarifies recurrence risk in MPS ICatherine Breen, Jean Mercer, Simon A Jones, et al.
Molecular Therapy. Methods & Clinical Development|April 13, 2019
Strategies for the Induction of Immune Tolerance to Enzyme Replacement Therapy in Mucopolysaccharidosis Type IArunabha Ghosh, Aiyin Liao, Claire O'Leary, et al.
The Journal of Pediatrics|March 28, 2009
Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapyRobert F Wynn, J Ed Wraith, Jean Mercer, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Molecular Genetics and Metabolism|June 1, 2013
Does early use of enzyme replacement therapy alter the natural history of mucopolysaccharidosis I? Experience in three siblingsSarah Laraway, Catherine Breen, Jean Mercer, et al.
International Journal of Pediatric Otorhinolaryngology|July 1, 2018
Transnasal adenoidectomy in mucopolysaccharidosisRebecca Harrison, Simone Schaefer, Laura Warner, et al.
The Journal of Pediatrics|October 30, 2016
Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type ISarah Laraway, Jean Mercer, Elisabeth Jameson, et al.
Plos One|September 19, 2018
Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapyAbhijit Ricky Pal, Jean Mercer, Simon A Jones, et al.
The Journal of Pediatrics|February 4, 2009
Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 patientsRobert F Wynn, Jean Mercer, Joanne Page, et al.
Journal of Inherited Metabolic Disease|March 19, 2011
The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome)Elke Miebach, Heather Church, Alan Cooper, et al.
Journal of Inherited Metabolic Disease|March 12, 2017
Long term survival and cardiopulmonary outcome in children with Hurler syndrome after haematopoietic stem cell transplantationSu Han Lum, Karolina M Stepien, Arunabha Ghosh, et al.
Human Genome Variation|October 22, 2016
Maternal mosaicism for <i>IDUA</i> deletion clarifies recurrence risk in MPS ICatherine Breen, Jean Mercer, Simon A Jones, et al.
Molecular Therapy. Methods & Clinical Development|April 13, 2019
Strategies for the Induction of Immune Tolerance to Enzyme Replacement Therapy in Mucopolysaccharidosis Type IArunabha Ghosh, Aiyin Liao, Claire O'Leary, et al.
The Journal of Pediatrics|March 28, 2009
Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapyRobert F Wynn, J Ed Wraith, Jean Mercer, et al.
Pageof 4